description About
50 million people worldwide have dementia, with 10 million new cases emerging annually. Alzheimer's disease is the most common form of dementia, but for 20-years, there have been no new drugs to tackle the disorder until now. In June, the US Food and Drug Administration approved Aducanumab, a new Alzheimer's medication. While this is a promising development, fierce debate surrounds its efficacy and approval process. FDA Advisory Committee member Dr. Alexander discusses this controversial drug.
Info
- verified Status: Returning Series
- person By: Unknown
- calendar_month Release Date: 2021-08-03
- video_camera_front Companies
- tag Season: Season 2
- timer Episode Runtime: Mins
- star Rating: 0 / 10
- visibilityViews:
-
starUser Ratings:
comment Comments